ReviewHematology, transfusion and cell therapy

All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia.

Reza Mirfakhraie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.